Phase 2a Randomized Placebo-Controlled Double-Blind Multicenter Trial of VIB4920 for Active Lupus Nephritis
Description
A double-blind, placebo-controlled trial of investigational agent combined with MMF.
Details
Age
Adult
Eligibility
SLE, UPCR greater than or equal to 1.5; age 18 or older
Type of Study
Treatment
Locations
Renal Research Center
University of Colorado Hospital
Principal Investigator
Amber Podoll, MD
Study ID
Protocol Number: 22-0596
More information available at ClinicalTrials.gov: NCT05201469
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers